Nu Skin Enterprises, Inc. (NUS)
| Previous close | 11.83 |
| Open | 12.02 |
| Bid | 12.14 x 900 |
| Ask | 12.19 x 800 |
| Day's range | 12.00 - 12.22 |
| 52-week range | 11.73 - 39.38 |
| Volume | |
| Avg. volume | 794,414 |
| Market cap | 601.188M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | 71.21 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (2.03%) |
| Ex-dividend date | 23 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
- PR Newswire
Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
- Business Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.
